Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginsenoside-Rd for Acute Ischemic Stroke
NCT00591084Phase 2Completed
- Sponsor
- Xijing Hospital
- Start
- Sep 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ginsenoside Rd in ischemic stroke (3 arms), sponsored by Xijing Hospital. Primary endpoint: National Institutes of Health Stroke Scale at 15 days. Started Sep 2005; status: completed.
02
Drugs
ginsenoside Rd
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00591084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00591084.